Cleo Diagnostics (ASX:COV) Interest Expense : A$ Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cleo Diagnostics's interest expense for the six months ended in Dec. 2023 was A$ -0.03 Mil. Cleo Diagnostics does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Dec. 2023.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cleo Diagnostics's Operating Income for the six months ended in Dec. 2023 was A$ -2.78 Mil. Cleo Diagnostics's Interest Expense for the six months ended in Dec. 2023 was A$ -0.03 Mil. Cleo Diagnostics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cleo Diagnostics Interest Expense Historical Data

The historical data trend for Cleo Diagnostics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Interest Expense Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Interest Expense

-0.11

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Interest Expense	-0.01	-0.11	-0.03

Cleo Diagnostics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Cleo Diagnostics (ASX:COV) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cleo Diagnostics's Interest Expense for the six months ended in Dec. 2023 was A$-0.03 Mil. Its Operating Income for the six months ended in Dec. 2023 was A$-2.78 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was A$0.00 Mil.

Cleo Diagnostics's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Cleo Diagnostics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines